Next, we demonstrate that compared to the control group, the MD group exhibited significantly increased expression levels of IL-1β and IL-18 (p<0.001), suggesting enhanced activity of these two inflammatory factors in MD patients. The gene discussed is IL1B; the disease is Menkes disease.